← Back to Clinical Trials
Recruiting NCT06270121

NCT06270121 Development of a Healthcare Service Platform for Successful Aging

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06270121
Status Recruiting
Phase —
Sponsor Sunmi Song
Condition Depression in Old Age
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2020-10-21
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Living-lab digital intervention group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 84 participants in total. It began in 2020-10-21 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this living-lab clinical trial is to test the effectiveness of digital health monitoring and feedback platform for community dwelling older adults. The main questions it aims to answer are: * Identify digital sensing variables that are predictive of mental and physical health declines and health emergencies of older adults * Develop digital health monitoring service to inform individualized daily health status of older adults users * Develop ICT network to share the daily health status and emergency signals with community based healthcare service providers and family caregivers if an older adult user approves of them to receive their health information. Participants will be asked to participate in a living lab using a wearable sensor, motion sensor, and smartphone applications for 6 weeks and also take part in pre-mid-post surveys to evaluate the usability, accuracy, and effectiveness of the digital healthcare service platform to improve health managements and connections with community and family caregivers. If there is a comparison group: Researchers will compare age and gender matched control group to see if health status of the living-lab group is better than the control group.

Eligibility Criteria

Inclusion Criteria: * Community dwelling older adults who are 65 years old and older Exclusion Criteria: * Older adults with cognitive, sensory, and functional problems that may hinder them from participating surveys. * Older adults with iOS mobile device that would not allow them to use the developed mobile application. * Older adults in nursing home or who are hospitalized because this platform is designed to support independent living of an older adults in their home.

Contact & Investigator

Central Contact

Sunmi Song, PhD

✉ sunmi.song0715@gmail.com

📞 +821087489593

Principal Investigator

Junesun Kim, PhD

PRINCIPAL INVESTIGATOR

Korea University

Frequently Asked Questions

Who can join the NCT06270121 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Depression in Old Age. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06270121 currently recruiting?

Yes, NCT06270121 is actively recruiting participants. Contact the research team at sunmi.song0715@gmail.com for enrollment information.

Where is the NCT06270121 trial being conducted?

This trial is being conducted at Seoul, South Korea.

Who is sponsoring the NCT06270121 clinical trial?

NCT06270121 is sponsored by Sunmi Song. The principal investigator is Junesun Kim, PhD at Korea University. The trial plans to enroll 84 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology